Jupiter Topco’s Damora Therapeutics DMRA Stock Holding History

Jupiter Topco’s Portfolio DMRA Stock Details DMRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$59.3M	Buy	+2,282,804	New	+$55.3M	0.02%	408

Other funds holding DMRA

Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Remedium Capital Partners Fort Lauderdale, Florida $452M AUM

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

JP Morgan Chase

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Jupiter Topco's DMRA Position: Q2 2026 in Review

Jupiter Topco opened a new position in Damora Therapeutics (DMRA) in Q2 2026: 2,282,804 shares worth $59.3M. The stake represents 0.02% of the portfolio and ranks #408 among its holdings.

94 funds tracked by Wall St. Rank hold DMRA as of Q2 2026.

Jupiter Topco held 2,282,804 shares of Damora Therapeutics worth $59.3M as of Q2 2026.
Damora Therapeutics was a new Jupiter Topco position in Q2 2026.
Damora Therapeutics made up 0.02% of Jupiter Topco's portfolio in Q2 2026, its #408 holding.
94 funds tracked by Wall St. Rank held Damora Therapeutics as of Q2 2026.

Based on Jupiter Topco's 13F filing for Q2 2026, filed 14 Aug 2026.